Original language | English |
---|---|
Title of host publication | Encyclopedia of Health Economics |
Editors | Anthony Culyer |
Publisher | Elsevier |
Chapter | 01401 |
Pages | 340-347 |
Number of pages | 8 |
ISBN (Electronic) | 9780123756787 |
ISBN (Print) | 978-0-12-375679-4 |
DOIs | |
Publication status | Published - 2014 |
Externally published | Yes |
Abstract
Introduction
In countries such as Australia, the UK, and Canada, public funding decisions for health technologies (e.g., pharmaceuticals) are based predominantly on cost-effectiveness data. National reimbursement bodies in these countries, such as the Pharmaceutical Benefits Advisory Committee in Australia and National Institute for Health and Clinical Excellence in the UK,provide guidance to the government, which form the basis of decisions around public funding of new health technologies.Most often, this process involves using decision analytic models to inform reimbursement approval at the national level.
In countries such as Australia, the UK, and Canada, public funding decisions for health technologies (e.g., pharmaceuticals) are based predominantly on cost-effectiveness data. National reimbursement bodies in these countries, such as the Pharmaceutical Benefits Advisory Committee in Australia and National Institute for Health and Clinical Excellence in the UK,provide guidance to the government, which form the basis of decisions around public funding of new health technologies.Most often, this process involves using decision analytic models to inform reimbursement approval at the national level.
Keywords
- Healthcare technologies
- economic evaluation
- decision analytic model
- Reference model
- Economic evaluation
- Depression
- Decision analytic model
- Model uncertainty
- Structural uncertainty